{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:58:16Z","timestamp":1791928696042,"version":"4.3.4"},"reference-count":37,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"12","license":[{"start":{"date-parts":[[2018,10,30]],"date-time":"2018-10-30T00:00:00Z","timestamp":1540857600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2018,10,30]]},"DOI":"10.1167\/iovs.18-24287","type":"journal-article","created":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T12:13:07Z","timestamp":1541074387000},"page":"5277","source":"Crossref","is-referenced-by-count":19,"title":["Semaphorin 3F Modulates Corneal Lymphangiogenesis and Promotes Corneal Graft Survival"],"prefix":"10.1167","volume":"59","author":[{"given":"Tristan","family":"Reuer","sequence":"first","affiliation":[{"name":"Eye Center, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Charlott","family":"Schneider","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertan","family":"Cakir","sequence":"additional","affiliation":[{"name":"Eye Center, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anima D.","family":"B\u00fchler","sequence":"additional","affiliation":[{"name":"Eye Center, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna M.","family":"Walz","sequence":"additional","affiliation":[{"name":"Eye Center, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thabo","family":"Lapp","sequence":"additional","affiliation":[{"name":"Eye Center, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Lange","sequence":"additional","affiliation":[{"name":"Eye Center, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hansj\u00fcrgen","family":"Agostini","sequence":"additional","affiliation":[{"name":"Eye Center, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnther","family":"Schlunck","sequence":"additional","affiliation":[{"name":"Eye Center, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Cursiefen","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Cologne, Cologne, Germany"},{"name":"Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Reinhard","sequence":"additional","affiliation":[{"name":"Eye Center, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Bock","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Cologne, Cologne, Germany"},{"name":"Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Stahl","sequence":"additional","affiliation":[{"name":"Eye Center, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"i1552-5783-59-12-5277-b01","doi-asserted-by":"crossref","unstructured":"Bachmann B, Taylor RS, Cursiefen C. Corneal neovascularization as a risk factor for graft failure and rejection after keratoplasty: an evidence-based meta-analysis. Ophthalmology. 2010; 117: 1300\u20131305.e7.","DOI":"10.1016\/j.ophtha.2010.01.039"},{"key":"i1552-5783-59-12-5277-b02","doi-asserted-by":"crossref","unstructured":"Cursiefen C, Cao J, Chen L, et al. Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival. Invest Ophthalmol Vis Sci. 2004; 45: 2666\u20132673.","DOI":"10.1167\/iovs.03-1380"},{"key":"i1552-5783-59-12-5277-b03","doi-asserted-by":"crossref","unstructured":"Buehler A, Sitaras N, Favret S, et al. Semaphorin 3F forms an anti-angiogenic barrier in outer retina. FEBS Lett. 2013; 587: 1650\u20131655.","DOI":"10.1016\/j.febslet.2013.04.008"},{"key":"i1552-5783-59-12-5277-b04","doi-asserted-by":"crossref","unstructured":"Sun Y, Liegl R, Gong Y, et al. Sema3f protects against subretinal neovascularization in vivo. EBioMedicine. 2017; 18: 281\u2013287.","DOI":"10.1016\/j.ebiom.2017.03.026"},{"key":"i1552-5783-59-12-5277-b05","doi-asserted-by":"crossref","unstructured":"Takahashi T, Fournier A, Nakamura F, et al. Plexin-neuropilin-1 complexes form functional semaphorin-3A receptors. Cell. 1999; 99: 59\u201369.","DOI":"10.1016\/S0092-8674(00)80062-8"},{"key":"i1552-5783-59-12-5277-b06","doi-asserted-by":"crossref","unstructured":"Suto F, Ito K, Uemura M, et al. Plexin-a4 mediates axon-repulsive activities of both secreted and transmembrane semaphorins and plays roles in nerve fiber guidance. J Neurosci. 2005; 25: 3628\u20133637.","DOI":"10.1523\/JNEUROSCI.4480-04.2005"},{"key":"i1552-5783-59-12-5277-b07","doi-asserted-by":"crossref","unstructured":"Behar O, Mizuno K, Badminton M, Woolf CJ. Semaphorin 3A growth cone collapse requires a sequence homologous to tarantula hanatoxin. Proc Natl Acad Sci U S A. 1999; 96: 13501\u201313505.","DOI":"10.1073\/pnas.96.23.13501"},{"key":"i1552-5783-59-12-5277-b08","doi-asserted-by":"crossref","unstructured":"Kessler O, Shraga-Heled N, Lange T, et al. Semaphorin-3F is an inhibitor of tumor angiogenesis. Cancer Res. 2004; 64: 1008\u20131015.","DOI":"10.1158\/0008-5472.CAN-03-3090"},{"key":"i1552-5783-59-12-5277-b09","doi-asserted-by":"crossref","unstructured":"Bielenberg DR, Klagsbrun M. Targeting endothelial and tumor cells with semaphorins. Cancer Metastasis Rev. 2007; 26: 421\u2013431.","DOI":"10.1007\/s10555-007-9097-4"},{"key":"i1552-5783-59-12-5277-b10","doi-asserted-by":"crossref","unstructured":"Sakurai A, Do\u00e7i CL, Doci C, Gutkind JS. Semaphorin signaling in angiogenesis, lymphangiogenesis and cancer. Cell Res. 2012; 22: 23\u201332.","DOI":"10.1038\/cr.2011.198"},{"key":"i1552-5783-59-12-5277-b11","doi-asserted-by":"crossref","unstructured":"Sharma A, LeVaillant CJ, Plant GW, Harvey AR. Changes in expression of Class 3 Semaphorins and their receptors during development of the rat retina and superior colliculus. BMC Dev Biol. 2014; 14: 34.","DOI":"10.1186\/s12861-014-0034-9"},{"key":"i1552-5783-59-12-5277-b12","doi-asserted-by":"crossref","unstructured":"McKenna CC, Ojeda AF, Spurlin J, Kwiatkowski S, Lwigale PY. Sema3A maintains corneal avascularity during development by inhibiting VEGF induced angioblast migration. Dev Biol. 2014; 391: 241\u2013250.","DOI":"10.1016\/j.ydbio.2014.04.017"},{"key":"i1552-5783-59-12-5277-b13","doi-asserted-by":"crossref","unstructured":"Cursiefen C. Immune privilege and angiogenic privilege of the cornea. Chem Immunol Allergy. 2007; 92: 50\u201357.","DOI":"10.1159\/000099253"},{"key":"i1552-5783-59-12-5277-b14","doi-asserted-by":"crossref","unstructured":"Bock F, Maruyama K, Regenfuss B, et al. Novel anti(lymph)angiogenic treatment strategies for corneal and ocular surface diseases. Prog Retin Eye Res. 2013; 34: 89\u2013124.","DOI":"10.1016\/j.preteyeres.2013.01.001"},{"key":"i1552-5783-59-12-5277-b15","doi-asserted-by":"crossref","unstructured":"Sonoda Y, Streilein JW. Orthotopic corneal transplantation in mice--evidence that the immunogenetic rules of rejection do not apply. Transplantation. 1992; 54: 694\u2013704.","DOI":"10.1097\/00007890-199210000-00026"},{"key":"i1552-5783-59-12-5277-b16","doi-asserted-by":"crossref","unstructured":"Niederkorn JY. Corneal transplantation and immune privilege. Int Rev Immunol. 2013; 32: 57\u201367.","DOI":"10.3109\/08830185.2012.737877"},{"key":"i1552-5783-59-12-5277-b17","doi-asserted-by":"crossref","unstructured":"Jabbehdari S, Rafii AB, Yazdanpanah G, Hamrah P, Holland EJ, Djalilian AR. Update on the management of high-risk penetrating keratoplasty. Curr Ophthalmol Rep. 2017; 5: 38\u201348.","DOI":"10.1007\/s40135-017-0119-2"},{"key":"i1552-5783-59-12-5277-b18","doi-asserted-by":"crossref","unstructured":"The Collaborative Corneal Transplantation Studies Research Group. The collaborative corneal transplantation studies (CCTS). Effectiveness of histocompatibility matching in high-risk corneal transplantation. Arch Ophthalmol. 1992; 110: 1392\u20131403.","DOI":"10.1001\/archopht.1992.01080220054021"},{"key":"i1552-5783-59-12-5277-b19","doi-asserted-by":"crossref","unstructured":"Bock F, Onderka J, Hos D, Horn F, Martus P, Cursiefen C. Improved semiautomatic method for morphometry of angiogenesis and lymphangiogenesis in corneal flatmounts. Exp Eye Res. 2008; 87: 462\u2013470.","DOI":"10.1016\/j.exer.2008.08.007"},{"key":"i1552-5783-59-12-5277-b20","doi-asserted-by":"crossref","unstructured":"Cursiefen C, Cao J, Chen L, et al. Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival. Invest Ophthalmol Vis Sci. 2004; 45: 2666\u20132673.","DOI":"10.1167\/iovs.03-1380"},{"key":"i1552-5783-59-12-5277-b21","doi-asserted-by":"crossref","unstructured":"Stahl A, Paschek L, Martin G, et al. Rapamycin reduces VEGF expression in retinal pigment epithelium (RPE) and inhibits RPE-induced sprouting angiogenesis in vitro. FEBS Lett. 2008; 582: 3097\u20133102.","DOI":"10.1016\/j.febslet.2008.08.005"},{"key":"i1552-5783-59-12-5277-b22","doi-asserted-by":"crossref","unstructured":"Maruyama K, Ii M, Cursiefen C, et al. Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest. 2005; 115: 2363\u20132372.","DOI":"10.1172\/JCI23874"},{"key":"i1552-5783-59-12-5277-b23","doi-asserted-by":"crossref","unstructured":"Dejda A, Mawambo G, Cerani A, et al. Neuropilin-1 mediates myeloid cell chemoattraction and influences retinal neuroimmune crosstalk. J Clin Invest. 2014; 124: 4807\u20134822.","DOI":"10.1172\/JCI76492"},{"key":"i1552-5783-59-12-5277-b24","doi-asserted-by":"crossref","unstructured":"Dietrich T, Bock F, Yuen D, et al. Cutting edge: lymphatic vessels, not blood vessels, primarily mediate immune rejections after transplantation. J Immunol. 2010; 184: 535\u2013539.","DOI":"10.4049\/jimmunol.0903180"},{"key":"i1552-5783-59-12-5277-b25","unstructured":"Azar DT. Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 2006; 104: 264\u2013302."},{"key":"i1552-5783-59-12-5277-b26","doi-asserted-by":"crossref","unstructured":"Ellenberg D, Azar DT, Hallak JA, et al. Novel aspects of corneal angiogenic and lymphangiogenic privilege. Prog Retin Eye Res. 2010; 29: 208\u2013248.","DOI":"10.1016\/j.preteyeres.2010.01.002"},{"key":"i1552-5783-59-12-5277-b27","doi-asserted-by":"crossref","unstructured":"Albuquerque RJC, Hayashi T, Cho WG, et al. Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth. Nat Med. 2009; 15: 1023\u20131030.","DOI":"10.1038\/nm.2018"},{"key":"i1552-5783-59-12-5277-b28","doi-asserted-by":"crossref","unstructured":"Ambati BK, Nozaki M, Singh N, et al. Corneal avascularity is due to soluble VEGF receptor-1. Nature. 2006; 443: 993\u2013997.","DOI":"10.1038\/nature05249"},{"key":"i1552-5783-59-12-5277-b29","doi-asserted-by":"crossref","unstructured":"Cursiefen C, Chen L, Saint-Geniez M, et al. Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision. Proc Natl Acad Sci U S A. 2006; 103: 11405\u201311410.","DOI":"10.1073\/pnas.0506112103"},{"key":"i1552-5783-59-12-5277-b30","doi-asserted-by":"crossref","unstructured":"Adams RH, Lohrum M, Klostermann A, Betz H, P\u00fcschel AW. The chemorepulsive activity of secreted semaphorins is regulated by furin-dependent proteolytic processing. EMBO J. 1997; 16: 6077\u20136086.","DOI":"10.1093\/emboj\/16.20.6077"},{"key":"i1552-5783-59-12-5277-b31","doi-asserted-by":"crossref","unstructured":"Guo H-F, Li X, Parker MW, Waltenberger J, Becker PM, Vander Kooi CW. Mechanistic basis for the potent anti-angiogenic activity of semaphorin 3F. Biochemistry. 2013; 52: 7551\u20137558.","DOI":"10.1021\/bi401034q"},{"key":"i1552-5783-59-12-5277-b32","doi-asserted-by":"crossref","unstructured":"Hattori T, Saban DR, Emami-Naeini P, et al. Donor-derived, tolerogenic dendritic cells suppress immune rejection in the indirect allosensitization-dominant setting of corneal transplantation. J Leukoc Biol. 2012; 91: 621\u2013627.","DOI":"10.1189\/jlb.1011500"},{"key":"i1552-5783-59-12-5277-b33","doi-asserted-by":"crossref","unstructured":"Bock F, R\u00f6ssner S, Onderka J, et al. Topical application of soluble CD83 induces IDO-mediated immune modulation, increases Foxp3+ T cells, and prolongs allogeneic corneal graft survival. J Immunol. 2013; 191: 1965\u20131975.","DOI":"10.4049\/jimmunol.1201531"},{"key":"i1552-5783-59-12-5277-b34","doi-asserted-by":"crossref","unstructured":"Zhang B, Gao Z, Sun M, et al. Prognostic significance of VEGF-C, semaphorin 3F, and neuropilin-2 expression in oral squamous cell carcinomas and their relationship with lymphangiogenesis. J Surg Oncol. 2015; 111: 382\u2013388.","DOI":"10.1002\/jso.23842"},{"key":"i1552-5783-59-12-5277-b35","doi-asserted-by":"crossref","unstructured":"Do\u00e7i CL, Mikelis CM, Lionakis MS, Molinolo AA, Gutkind JS. Genetic identification of SEMA3F as an anti-lymphangiogenic metastasis suppressor gene in head and neck squamous carcinoma. Cancer Res. 2015; 75: 2937\u20132948.","DOI":"10.1158\/0008-5472.CAN-14-3121"},{"key":"i1552-5783-59-12-5277-b36","doi-asserted-by":"crossref","unstructured":"Uchida Y, James JM, Suto F, Mukouyama Y-S. Class 3 semaphorins negatively regulate dermal lymphatic network formation. Biol Open. 2015; 4: 1194\u20131205.","DOI":"10.1242\/bio.012302"},{"key":"i1552-5783-59-12-5277-b37","doi-asserted-by":"crossref","unstructured":"Mendes-da-Cruz DA, Brignier AC, Asnafi V, et al. Semaphorin 3F and neuropilin-2 control the migration of human T-cell precursors. PLoS One. 2014; 9: e103405.","DOI":"10.1371\/journal.pone.0103405"}],"container-title":["Investigative Opthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?articleid=2712199","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:30:58Z","timestamp":1791927058000},"score":1,"resource":{"primary":{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.18-24287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,30]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,10,1]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.18-24287","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10,30]]}}}